indazoles has been researched along with Fatty Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, Q; Li, W; Lou, J; Peng, C; Teng, Z; Xu, C; Yin, L; Zhang, C; Zhou, X | 1 |
| Afsar, B; Armagan, B; Bilgetekin, I; Cetin, B; Demirci, U; Gulbahar, O; Gumusay, O; Ozet, A; Uner, A; Yılmaz, GE | 1 |
| Cleary, J; Howard, SA; Jagannathan, JP; Krajewski, KM; O'Regan, K; Ramaiya, N; Thornton, E | 1 |
3 other study(ies) available for indazoles and Fatty Liver
| Article | Year |
|---|---|
Prevention of Obesity Related Diseases through Laminarin-induced targeted delivery of Bindarit.
Topics: Adipose Tissue; Animals; Atherosclerosis; Computer Simulation; Diet, High-Fat; Fatty Liver; Glucans; Humans; Indazoles; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Monocytes; Nanoparticles; Obesity; Plaque, Atherosclerotic; Propionates | 2020 |
Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Bilirubin; Blood Chemical Analysis; Blood Glucose; Chemical and Drug Induced Liver Injury; Fatty Liver; Hemosiderin; Indazoles; Kupffer Cells; Liver; Male; Pyrimidines; Rats; Rats, Wistar; Sulfonamides | 2018 |
Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemical and Drug Induced Liver Injury; Cholecystitis; Early Diagnosis; Edema; Fatty Liver; Female; Health Knowledge, Attitudes, Practice; Humans; Indazoles; Infections; Male; Middle Aged; Molecular Targeted Therapy; Neoplasms; Pancreatitis; Protein-Tyrosine Kinases; Pyrimidines; Radiography, Abdominal; Sulfonamides; Vascular Endothelial Growth Factor A; Young Adult | 2012 |